You're reading the free version. Trader adds the live tape and alerts.
Start tracking
MRNA Exercise Disclosure
Klinger Shannon Thyme · SEC Form 4 · Filed Sep 3, 2026
Exercise
Calculated transaction value
$0
Klinger Shannon Thyme Chief Legal Officer
MRNA
Moderna
MRNA
Transaction date
Sep 1, 2026
Public filing date
Sep 3, 2026
Filing lag
Filed 2 days later
MRNA daily price context
Close on/before transaction
$154.27
Sep 1, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Restricted Stock Units on Common Stock
- Quantity / price
- 2,166 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001682852-26-000167
Filing cohort
Transactions in this filing
Showing 6 of 6
Trades
6
Issuers
1
Estimated value
$740.3K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Moderna, Inc. MRNA | Exercise | Sep 1, 2026 | $107.46K |
| Moderna, Inc. MRNA | Exercise | Sep 1, 2026 | Not reported |
| Moderna, Inc. MRNA | Sale | Sep 1, 2026 | $485.77K |
| Moderna, Inc. MRNA | Disposition | Sep 1, 2026 | $147.08K |
| Moderna, Inc. MRNA | Exercise | Sep 1, 2026 | $0 |
| Moderna, Inc. MRNA Current | Exercise | Sep 1, 2026 | $0 |